18F-FDG PET imaging in primary adrenal lymphoma
10.3760/cma.j.issn.0253-9780.2011.04.008
- VernacularTitle:18F-FDG PET在原发性肾上腺淋巴瘤中的作用
- Author:
CHENG, XIN
;
ZHOU, QIAN
- Publication Type:Journal Article
- Keywords:
Adrenal gland neoplasms;
Lymphoma;
Tomography,emission-computed;
Deoxyglucose
- From:Chinese Journal of Nuclear Medicine
2011;31(4):237-240
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate 18F-FDG PET/CT imaging in primary adrenal lymphoma (PAL). Methods Three male patients with clinically diagnosed PAL, aged 59 to 77 years old, were examined by18F-FDG PET/CT before histopathologic examination. The SUVmax ratio of tumor to liver (T/L)was calculated on 18F-FDG PET images. All patients underwent R-CHOP ( rituximab-cyclophosphamide,doxorubicin, vincristine, and prednisone) chemotherapy regimens. One patient had serial follow-up 18F-FDG PET/CT post therapy. Results The final diagnosis of all 3 cases was bilateral diffuse large B-cell lymphoma. The pathologic results of bone marrow biopsy were negative. Case 1 was in disease remission based on four times of follow-up 18F-FDG PET/CT. The patient's clinical follow-up was also negative and he was currently alive for more than 19 months. Case 2 was of late stage and suffered from adrenal insufficiency. He died 6 months after the diagnosis. Case 3 (the eldest patient) was treated with partial excision followed by the chemotherapy. He died of lung infection 12 months after treatment. Conclusion 18 F-FDG PET/CT may be of important value for maximizing patient management and survival for patients with PAL, a rare and highly malignant disease.
